Drug Type AAV based gene therapy |
Synonyms gene regulation therapy (Sangamo Therapeutics/Novartis) |
Target- |
Mechanism Gene transference |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autistic Disorder | Preclinical | US | - | |
Autistic Disorder | Preclinical | CH | - | |
Deafness, Cochlear, With Myopia and Intellectual Impairment | Preclinical | CH | - | |
Deafness, Cochlear, With Myopia and Intellectual Impairment | Preclinical | US | - |